Compare Stocks: XLY, HIMS, GS, MS, GDRX, and ULTA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GDRX GoodRx	$3.63 +2.4%	$3.44	$1.77 ▼ $3.89	$1.24B	1.66	1.83 million shs	468,532 shs
GS The Goldman Sachs Group	$928.61 +2.0%	$927.53	$754.00 ▼ $1,153.99	$267.69B	1.29	2.21 million shs	863,512 shs
HIMS Hims & Hers Health	$20.64 +7.9%	$28.10	$13.74 ▼ $40.99	$4.81B	2.53	22.38 million shs	16.72 million shs
MS Morgan Stanley	$190.68 +1.7%	$194.14	$152.80 ▼ $232.25	$297.88B	1.23	6.21 million shs	2.78 million shs
ULTA Ulta Beauty	$656.58 -1.2%	$581.28	$443.60 ▼ $714.97	$28.06B	0.83	651,141 shs	175,062 shs
XLY Consumer Discretionary Select Sector SPDR Fund	$121.07 +0.0%	$113.52	$105.19 ▼ $125.01	$23.64B	1.2	8.75 million shs	4.19 million shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GDRX GoodRx	-3.01%	+1.43%	+3.21%	-1.39%	+15.69%
GS The Goldman Sachs Group	+0.28%	+1.79%	+1.66%	-12.03%	+14.22%
HIMS Hims & Hers Health	-16.89%	-25.98%	-38.35%	-36.21%	-53.72%
MS Morgan Stanley	+0.22%	+0.85%	-1.27%	-13.86%	+13.67%
ULTA Ulta Beauty	-0.11%	+4.65%	+16.49%	+24.91%	+28.62%
XLY Consumer Discretionary Select Sector SPDR Fund	+0.03%	+3.17%	+7.27%	+2.68%	+1.31%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GDRX GoodRx	$3.63 +2.4%	$3.44	$1.77 ▼ $3.89	$1.24B	1.66	1.83 million shs	468,532 shs
GS The Goldman Sachs Group	$928.61 +2.0%	$927.53	$754.00 ▼ $1,153.99	$267.69B	1.29	2.21 million shs	863,512 shs
HIMS Hims & Hers Health	$20.64 +7.9%	$28.10	$13.74 ▼ $40.99	$4.81B	2.53	22.38 million shs	16.72 million shs
MS Morgan Stanley	$190.68 +1.7%	$194.14	$152.80 ▼ $232.25	$297.88B	1.23	6.21 million shs	2.78 million shs
ULTA Ulta Beauty	$656.58 -1.2%	$581.28	$443.60 ▼ $714.97	$28.06B	0.83	651,141 shs	175,062 shs
XLY Consumer Discretionary Select Sector SPDR Fund	$121.07 +0.0%	$113.52	$105.19 ▼ $125.01	$23.64B	1.2	8.75 million shs	4.19 million shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GDRX GoodRx	-3.01%	+1.43%	+3.21%	-1.39%	+15.69%
GS The Goldman Sachs Group	+0.28%	+1.79%	+1.66%	-12.03%	+14.22%
HIMS Hims & Hers Health	-16.89%	-25.98%	-38.35%	-36.21%	-53.72%
MS Morgan Stanley	+0.22%	+0.85%	-1.27%	-13.86%	+13.67%
ULTA Ulta Beauty	-0.11%	+4.65%	+16.49%	+24.91%	+28.62%
XLY Consumer Discretionary Select Sector SPDR Fund	+0.03%	+3.17%	+7.27%	+2.68%	+1.31%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GDRX GoodRx	2.08	Hold	$4.15	14.48% Upside
GS The Goldman Sachs Group	2.44	Hold	$1,052.04	13.29% Upside
HIMS Hims & Hers Health	2.13	Hold	$31.53	52.79% Upside
MS Morgan Stanley	2.52	Moderate Buy	$214.81	12.65% Upside
ULTA Ulta Beauty	2.78	Moderate Buy	$635.87	-3.15% Downside
XLY Consumer Discretionary Select Sector SPDR Fund	2.69	Moderate Buy	$121.07	0.00% Upside

Current Analyst Ratings Breakdown

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/10/2026	HIMS Hims & Hers Health	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Hold	$31.00 ➝ $24.00
11/10/2026	HIMS Hims & Hers Health	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Equal Weight	$28.00 ➝ $25.00
11/10/2026	HIMS Hims & Hers Health	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$42.00 ➝ $32.00
11/6/2026	ULTA Ulta Beauty	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral	$580.00 ➝ $685.00
11/4/2026	GDRX GoodRx	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D+)
11/4/2026	HIMS Hims & Hers Health	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D)
11/3/2026	MS Morgan Stanley	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy (B)
11/2/2026	GS The Goldman Sachs Group	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Neutral	$1,010.00 ➝ $1,000.00
11/2/2026	MS Morgan Stanley	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$236.00 ➝ $240.00
10/30/2026	ULTA Ulta Beauty	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Strong-Buy
10/28/2026	GS The Goldman Sachs Group	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C+) ➝ Hold (C)

(Data available from 11/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GDRX GoodRx	$796.85M	1.56	$0.40 per share	9.12	$1.81 per share	2.00
GS The Goldman Sachs Group	$125.10B	2.14	$66.14 per share	14.04	$381.89 per share	2.43
HIMS Hims & Hers Health	$2.35B	2.05	$0.75 per share	27.41	$2.38 per share	8.67
MS Morgan Stanley	$119.66B	2.49	$13.80 per share	13.82	$69.46 per share	2.75
ULTA Ulta Beauty	$12.39B	2.27	$32.36 per share	20.29	$63.19 per share	10.39
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GDRX GoodRx	$30.44M	$0.04	90.65	18.13	N/A	2.07%	7.22%	2.53%	N/A
GS The Goldman Sachs Group	$17.18B	$69.55	13.34	12.56	0.85	15.77%	20.21%	1.08%	1/19/2027 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	46.90	N/A	-6.65%	-9.17%	-1.49%	N/A
MS Morgan Stanley	$16.86B	$12.60	15.13	14.29	1.25	15.63%	19.26%	1.28%	1/14/2027 (Estimated)
ULTA Ulta Beauty	$1.15B	$27.44	23.92	20.38	1.99	9.34%	45.40%	17.37%	12/3/2026 (Estimated)
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	27.10	N/A	N/A	N/A	N/A	N/A	N/A

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
12/3/2026	Q3 2027	ULTA Ulta Beauty	$5.63	N/A	N/A	N/A	$2.99 billion	N/A
10/14/2026	Q3 2026	MS Morgan Stanley	$2.93	$3.03	+$0.10	$3.03	$19.93 billion	$20.34 billion
10/13/2026	Q3 2026	GS The Goldman Sachs Group	$12.86	$17.01	+$4.15	$17.01	$16.83 billion	$18.68 billion
8/27/2026	Q2 2027	ULTA Ulta Beauty	$6.22	$6.55	+$0.33	$6.55	$2.99 billion	$3.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
GDRX GoodRx	N/A	N/A	N/A	N/A	N/A
GS The Goldman Sachs Group	$20.00	2.15%	+22.87%	28.76%	13 Years
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
MS Morgan Stanley	$4.60	2.41%	+22.42%	36.51%	12 Years
ULTA Ulta Beauty	N/A	N/A	N/A	N/A	N/A
XLY Consumer Discretionary Select Sector SPDR Fund	$0.93	0.77%	N/A	N/A	N/A

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
10/12/2026	GS The Goldman Sachs Group	quarterly	$5.00	2.24%	12/2/2026	12/2/2026	12/30/2026
10/14/2026	MS Morgan Stanley	quarterly	$1.15	2.49%	10/30/2026	10/30/2026	11/13/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GDRX GoodRx	0.74	1.38	1.38
GS The Goldman Sachs Group	3.20	0.61	0.61
HIMS Hims & Hers Health	4.21	0.93	0.87
MS Morgan Stanley	3.58	0.79	0.79
ULTA Ulta Beauty	N/A	1.35	0.29
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GDRX GoodRx	63.77%
GS The Goldman Sachs Group	71.21%
HIMS Hims & Hers Health	63.52%
MS Morgan Stanley	84.19%
ULTA Ulta Beauty	90.39%
XLY Consumer Discretionary Select Sector SPDR Fund	69.93%

Insider Ownership

Company	Insider Ownership
GDRX GoodRx	5.87%
GS The Goldman Sachs Group	0.55%
HIMS Hims & Hers Health	11.76%
MS Morgan Stanley	0.17%
ULTA Ulta Beauty	0.20%
XLY Consumer Discretionary Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GDRX GoodRx	697	342.57 million	322.47 million	Optionable
GS The Goldman Sachs Group	47,400	288.43 million	286.85 million	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
MS Morgan Stanley	82,992	1.56 billion	1.57 billion	Optionable
ULTA Ulta Beauty	65,000	42.76 million	42.67 million	Optionable
XLY Consumer Discretionary Select Sector SPDR Fund	147,000	195.26 million	N/A	Not Optionable

XLY, HIMS, GS, MS, GDRX, and ULTA Headlines

Recent News About These Companies

ETFs to Focus on Post-US Mid-Term Election Results

November 6, 2026 | zacks.com

XLY ETF Forecast & Price Targets

November 3, 2026 | tipranks.com

More Pain Ahead for Tech & Broader Market ETFs?

November 3, 2026 | zacks.com

4 Halloween ETF Treats for Investors

October 30, 2026 | zacks.com

Will Oil Prices Slump on Peace Hopes? ETFs in Focus

October 30, 2026 | zacks.com

State Street Consumer Discretionary (XLY) Adds Amazon and Tesla on Thursday

October 26, 2026 | finance.yahoo.com

[ETF Trivia] A desperate measure against weight concentration?

October 25, 2026 | note.comN

Tesla Earnings Test XLY After Sector-Leading 5-Day Run

October 22, 2026 | etftrends.comE

State Street Consumer Discretionary (XLY) Adds Amazon and Tesla on Oct. 20

October 22, 2026 | uk.finance.yahoo.com

State Street Consumer Discretionary (XLY) Sells $45.7 Million of Amazon on Oct. 19

October 21, 2026 | uk.finance.yahoo.com

Consumer Staples Are Having a Moment—and the Rally Could Continue

October 20, 2026 | barrons.com

What State Street Consumer Discretionary SPDR (XLY) Sold: Amazon Leads on Oct. 16

October 20, 2026 | uk.finance.yahoo.com

Should You Invest in the State Street Consumer Discretionary Select Sector SPDR ETF (XLY)?

October 20, 2026 | zacks.com

Oil Prices Are Back Above $100. History Says the Biggest Stock Market Loser May Now Offer the Biggest Upside.

October 17, 2026 | fool.com

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Amid Investor Caution

October 16, 2026 | finance.yahoo.com

State Street Investment Management Builds on Nearly 30 Years of Sector ETF Leadership with New Market Sector ETFs

October 15, 2026 | markets.ft.com

New State Street Sector ETFs Give Biggest Stocks Full Weight

October 14, 2026 | etftrends.comE

Amazon Prime Sale, Emmys Streaming Deal Put XLY in Focus

October 6, 2026 | etftrends.comE

4 ETFs to Capitalize on Major Drivers of Q4

October 6, 2026 | zacks.com

The ‘Funflation' Effect: What It May Mean for Retail Stocks

September 29, 2026 | etftrends.comE

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

XLY, HIMS, GS, MS, GDRX, and ULTA Company Descriptions

GoodRx NASDAQ:GDRX

$3.62 +0.09 (+2.40%)

As of 02:47 PM Eastern

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

The Goldman Sachs Group NYSE:GS

$928.61 +18.42 (+2.02%)

As of 02:48 PM Eastern

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Hims & Hers Health NYSE:HIMS

$20.64 +1.51 (+7.88%)

As of 02:48 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Morgan Stanley NYSE:MS

$190.68 +3.12 (+1.66%)

As of 02:48 PM Eastern

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.

Ulta Beauty NASDAQ:ULTA

$656.58 -7.84 (-1.18%)

As of 02:48 PM Eastern

Ulta Beauty, Inc. operates as a specialty beauty retailer in the United States. The company offers branded and private label beauty products, including cosmetics, fragrance, haircare, skincare, bath and body products, professional hair products, and salon styling tools through its Ulta Beauty stores, shop-in-shops, Ulta.com website, and its mobile applications. It also offers beauty services, including hair, makeup, brow, and skin services at its stores. The company was formerly known as ULTA Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois.

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

$121.07 +0.02 (+0.01%)

As of 02:48 PM Eastern

Consumer Discretionary Select Sector SPDR Fund seeks to provide investment results that correspond generally to the price and yield performance of the Consumer Discretionary Select Sector Index (the Index). The Index includes companies from the following industries, media; retail (specialty, multiline, Internet and catalog); hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure equipment and products; and diversified consumer services. The Fund's investment advisor is SSgA Funds Management, Inc.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Earnings

Compare Dividends

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

XLY, HIMS, GS, MS, GDRX, and ULTA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

XLY, HIMS, GS, MS, GDRX, and ULTA Company Descriptions

GoodRx NASDAQ:GDRX

The Goldman Sachs Group NYSE:GS

Hims & Hers Health NYSE:HIMS

Morgan Stanley NYSE:MS

Ulta Beauty NASDAQ:ULTA

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools